Akebia Therapeutics
AKBA
AKBA
144 hedge funds and large institutions have $339M invested in Akebia Therapeutics in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 49 increasing their positions, 44 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6.29% less ownership
Funds ownership: 71.79% → 65.5% (-6.3%)
40% less call options, than puts
Call options by funds: $2.14M | Put options by funds: $3.57M
Holders
144
Holding in Top 10
1
Calls
$2.14M
Puts
$3.57M
Top Buyers
| 1 | +$11M | |
| 2 | +$10.4M | |
| 3 | +$3.69M | |
| 4 |
BlackRock
New York
|
+$3.29M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.32M |
Top Sellers
| 1 | -$18.4M | |
| 2 | -$6.67M | |
| 3 | -$6.4M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.93M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$3.28M |